Anzeige
Erschienen in:
01.05.2022 | News item
Non-serious case reports
Erschienen in: Reactions Weekly | Ausgabe 1/2022
Einloggen, um Zugang zu erhaltenExcerpt
The table below provides a list of the drugs associated with non-serious adverse events identified in the scientific literature over the last week.|
Non-serious case reports
|
Adverse event(s)
|
No. of cases
|
|---|---|---|
|
Drug name(s)
|
||
|
Abiraterone acetate, Lutetium (177Lu) vipivotide tetraxetan, Prednisone
|
Haematological disorders
|
3
|
|
Acetyl tyrosine, Ascorbic acid, Biotin, Chromium, Cobalamin, Folic acid, Magnesium oxide, Nicotinamide, Omega 3 fatty acid, Pyridoxine, Retinol, Riboflavin, Selenium, Thiamine, Thioctic acid, Ubidecarenone, Vitamin B complex, Vitamin D, Vitamin E, Vitamin K, Vitamin K2, Zinc
|
Diarrhoea
|
1
|
|
Acitretin, Tacrolimus
|
Vitiligo
|
1
|
|
Aspirin
|
Gingival disorders, Haemorrhage
|
1
|
|
Atezolizumab, Pembrolizumab
|
Skin disorders
|
1
|
|
Atomoxetine
|
Ejaculation disorders
|
1
|
|
Atorvastatin, Sonidegib
|
Muscle spasticity
|
1
|
|
Azacitidine, Trametinib
|
Abnormal laboratory parameters
|
1
|
|
AZD 1222, Elasomeran, Tozinameran
|
Fever, Lymphadenopathy
|
26
|
|
Baclofen, Desvenlafaxine, Paracetamol, Tizanidine
|
Abnormal laboratory parameters, False test results
|
1
|
|
Biotin
|
Abnormal laboratory parameters
|
1
|
|
Bisoprolol
|
Fatigue, Nausea
|
2
|
|
Botulinum Toxin A
|
Encephalopathy, Epilepsy, Haematoma, Injection site pain, Injection site reactions, Odynophagia, Pain
|
4
|
|
Botulinum Toxin A
|
Injection site pain, Odynophagia, Xerostomia
|
10
|
|
Botulinum Toxin A
|
Pain
|
1
|
|
Butenafine/chlorphenamine/crotamiton/dibucaine/glycyrrhizin/isopropyl methylphenol/menthol, Chlorhexidine, Crotamiton, Lanoconazole, Terbinafine
|
Allergic contact dermatitis
|
7
|
|
Calcitriol, Calcium carbonate, Calcium gluconate
|
Hypercalcaemia
|
1
|
|
Camrelizumab
|
Fever, Haemangioma
|
2
|
|
Celecoxib, Naproxen
|
Gastric disorders, Nausea, Pain
|
2
|
|
Cetuximab
|
Fever, Infusion related reaction
|
2
|
|
Cisplatin, Erlotinib, Gefitinib, Pembrolizumab, Pemetrexed
|
Asthenia, Diarrhoea, Exanthema, Kidney disorders
|
2
|
|
COVID 19 Vaccine Pfizer BioNTech
|
Hyperglycaemia
|
1
|
|
Cytarabine
|
Ataxia
|
1
|
|
Darunavir/ritonavir, Palbociclib
|
Abnormal laboratory parameters
|
1
|
|
Desmopressin
|
Hyponatraemia
|
1
|
|
Doxycycline
|
Anorexia, Nausea
|
1
|
|
Dupilumab
|
Pregnancy
|
1
|
|
Dupilumab
|
Pustular psoriasis
|
1
|
|
Elasomeran
|
Chilblains, Skin disorders
|
1
|
|
Elasomeran
|
Erythema nodosum
|
1
|
|
Elasomeran
|
Hypersensitivity
|
1
|
|
Emtricitabine/tenofovir disoproxil fumarate
|
Hyperparathyroidism
|
1
|
|
Ferric carboxymaltose
|
Hypophosphataemia
|
1
|
|
Forodesine
|
Lymphopenia
|
1
|
|
Gadoterate meglumine
|
Alopecia
|
1
|
|
Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune, V 503
|
Injection site pain
|
1
|
|
Hydrocortisone
|
Abnormal laboratory parameters
|
1
|
|
Hydroxocobalamin
|
Urination disorders
|
1
|
|
Icotinib
|
Diarrhoea, Gastrointestinal disorders
|
1
|
|
Indometacin
|
Anxiety, Dissociative disorders, Lightheadedness
|
1
|
|
Insulin degludec/insulin aspart
|
Hypoglycaemia
|
2
|
|
Insulin, Insulin aspart, Insulin degludec, Insulin detemir, Insulin glargine, Insulin glulisine, Insulin lispro, Insulin suspension isophane
|
Lipoatrophy
|
13
|
|
Isotretinoin
|
Elevated aminotransferase levels
|
1
|
|
Ixekizumab
|
Respiratory tract infections
|
1
|
|
Ixekizumab, Secukinumab
|
Vitiligo
|
1
|
|
Levodopa/benserazide
|
Dyskinesias
|
1
|
|
Levonorgestrel
|
Breast disorders, Headache, Hot flashes, Meteorism, Vaginal diseases, Weight gain
|
6
|
|
Lidocaine, Ropivacaine
|
Hoarseness
|
2
|
|
Melatonin
|
Sleep disorders
|
1
|
|
Mepolizumab
|
Exanthema, Headache, Injection site reactions
|
2
|
|
Midazolam, Phenobarbital
|
Hypotonia
|
1
|
|
Moxifloxacin, Rifampicin
|
Exanthema, Mental disorders, Urticaria
|
1
|
|
Neomycin
|
Contact dermatitis
|
1
|
|
Nifedipine
|
Gingival hyperplasia
|
1
|
|
Nivolumab
|
Diarrhoea, Fatigue
|
1
|
|
Panitumumab
|
Hair disorders, Skin disorders, Trichomegaly
|
1
|
|
Pantoprazole
|
Hyperhidrosis
|
1
|
|
Pembrolizumab
|
Pruritus
|
1
|
|
Phenazopyridine
|
Delayed hypersensitivity
|
1
|
|
Prednisolone
|
Insomnia
|
1
|
|
Propofol
|
Stuttering
|
1
|
|
Sacubitril/valsartan
|
Hyponatraemia
|
1
|
|
Sarilumab
|
Skin eruptions
|
1
|
|
Somatropin
|
Lichenoid eruptions
|
1
|
|
Spironolactone
|
Headache, Menstruation disorders
|
1
|
|
Testosterone cipionate
|
Fatigue, Weight gain
|
1
|
|
Thiamine
|
Extravasation, Phlebitis
|
1
|
|
Tofacitinib
|
Abscess, Vomiting
|
2
|
|
Tozinameran
|
Olfaction disorders
|
2
|
|
Trastuzumab emtansine
|
Infusion related reaction
|
1
|
|
Upadacitinib
|
Molluscum contagiosum
|
1
|
|
Ziconotide
|
Headache, Vascular disorders
|
2
|